Identifying “at-risk” patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections

Benzer Materyaller

• Continuous beta-lactam infusion in critically ill patients: the clinical evidence
  Yazar:: Abdul-Aziz, Mohd H, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review
  Yazar:: Sime, Fekade Bruck, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
  Yazar:: Cotta, Menino Osbert, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Beta-lactam antibiotics in continuous infusion in critically ill patients
  Yazar:: Jeurissen, Axel, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• OTAC: Optimization of Antibiotic Therapy in Critically ill Patients. Using beta-lactam antibiotics by continuous infusion
  Yazar:: Erika Esteve-Pitarch, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)